Director/PDMR Shareholding

RNS Number : 9377U

GlaxoSmithKline PLC

03 January 2012

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

On 30 December 2011, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares and American Depositary Shares (ADSs) in the Company through the annual reinvestment of dividends paid throughout 2011:

GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award - Annual Dividend Reinvestment

Non-Executive Director	No. of Ordinary Shares	Average Price (£)	No. of ADSs	Average Price ($)
Sir Christopher Gent	3,072.732	14.70
Prof Sir Roy Anderson	408.069	14.70
Dr Stephanie Burns			361.105	45.53
Ms Stacey Cartwright	3.865	14.70
Mr Lawrence Culp			1,133.685	45.53
Sir Crispin Davis	2,536.065	14.70
Ms Judy Lewent			0.613	45.53
Sir Deryck Maughan			1,033.536	45.53
Mr James Murdoch	474.157	14.70
Dr Daniel Podolsky			623.023	45.53
Mr Tom de Swaan	612.754	14.70
Sir Robert Wilson	710.997	14.70

The Company and the Non-Executive Directors were informed of these allocations on

3 January 2012.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 January 2012

 

END

 

 

RDSDXLFBLFFLBBK